5 of 6
Leiner Health Products
Leiner Health Products

A Food and Drug Administration investigation at Leiner Health Product's plant in Fort Mill, S.C., found that the drugmaker's manufacturing practices were not up to snuff. That prompted Leiner to suspend production and issue a recall of its over-the-counter allergy and pain-relief drugs, which accounted for 30% of the company's annual sales.

Six months later, the Department of Justice launched a separate investigation at the same production facility. That drove Leiner's top customers, including major drugstore chains and wholesale giants, to take their business to competitors, the company said.

The severe sales drop forced Leiner to downsize its workforce by 40% and consolidate its manufacturing facilities. One year after the recall, Leiner filed for bankruptcy protection to restructure debt of nearly $436 million. Just a few months later, vitamin and supplement manufacturer NBTY Inc. bought Leiner for $371 million.

NEXT: GM and Chrysler

Email | Print | Share  |  RSS
google my aol my msn my yahoo! netvibes
Paste this link into your favorite RSS desktop reader
See all CNNMoney.com RSS FEEDS (close)
LAST UPDATE: Mar 23 2010 | 5:30 AM ET
More Galleries
7 hot businesses to start now It's hard to predict what businesses will take off, but these startup ideas have been drawing tons of interest from entrepreneurs and their customers on Thumbtack.com. More
How will a minimum wage hike hit businesses? Thirteen states increased the minimum wage on Jan. 1, and President Obama supports raising the federal rate to $10.10. 4 small business owners weigh in on how an increase would affect them. More
America's favorite businesses From a science camp for girls to a kombucha brewer, communities around the country voted on their favorite small businesses. These 12 came out on top, each scoring a $250,000 grant from Chase and a trip to Google's headquarters. More

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.